| |
|
|
|
| Unsafe Drugs
:: Avandia
|
AVANDIA - Avandia has been linked to heart attacks, congestive heart failure, liver damage, kidney problems, and increased bone thinning in both men and women. The diabetes drug, manufactured by pharmaceutical giant GlaskoSmithKline (NYSE: GSK), is under increased scrutiny leading concerned citizens to call for the FDA to ban the drug. Unfortunately, the drug is causing more problems than it is worth.
If you have been prescribed Avandia to treat diabetes and you have suffered from congestive heart failure or a heart attack, you need to contact an attorney. The prescription may have been for Avandia, Avandamet, or Avandaryl, which are alternate forms of Avandia. In addition, long term exposure by women has led to osteoporosis, increasing propensity for bone fractures and disabilities.
Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of taking Avandia, please fill out the form below for a free evaluation.
Keywords: Avandia Lawsuit | Avandia Lawyer | Avandia Attorney | Avandia Lawyers | Avandia Attorneys
|
| Free Case Evaluation |
Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.
|
| Avandia In the News |
FDA Asks For “Restraint” On Drug Safety Worries - Forbes (blog)
FDA Asks For “Restraint” On Drug Safety WorriesForbes (blog)The main point of the article is to explain why FDA is not removing Spiriva (generic name: tiotropium), a treatment for chronic obstructive pulmonary ...
More Information »
UK experts advised rosiglitazone withdrawal in July - TheHeart.Org
Telegraph.co.ukUK experts advised rosiglitazone withdrawal in JulyTheHeart.OrgThe documentary sketches the history of rosiglitazone, as chronicled by heartwire, up to and including the US FDA advisory committee meeting this...
More Information »
EMA poses new questions on Avandia - FiercePharma
EMA poses new questions on AvandiaFiercePharmaMeanwhile, FDA is due to decide how to proceed; that determination is expected next week. GSK maintains that the drug is safe when used according to its ...and more »
More Information »
FDA Reviewer, Expert Panelists, Not Happy with Avandia Letter - MedPage Today (blog)
Health JackalFDA Reviewer, Expert Panelists, Not Happy with Avandia LetterMedPage Today (blog)Within the next few weeks, the FDA will make a much-anticipated decision on the fate of rosiglitazone (Avandia), the diabetes drug...
More Information »
Study: Diet Drug Meridia May Boost Heart Risks - TIME
Health JackalStudy: Diet Drug Meridia May Boost Heart RisksTIMECommissioner Margaret Hamburg is still weighing similar evidence regarding the diabetes drug Avandia, or rosiglitazone. An advisory committee recommended in...
More Information »
Glaxo Memo on Avandia Is Questioned - New York Times (blog)
Glaxo Memo on Avandia Is QuestionedNew York Times (blog)... disagreed and said the company's letter “faithfully reflects the deliberations of the Avandia advisory meeting.” Erica Jefferson, an FDA spokeswoman, ...TIME:...
More Information »
AM Vitals: Looking to Progeria for Clues to Heart Disease - Wall Street Journal (blog)
AM Vitals: Looking to Progeria for Clues to Heart DiseaseWall Street Journal (blog)Avandia Debate: The British Medical Journal says GlaxoSmithKline's much-debated diabetes drug Avandia should never have been approved in...
More Information »
Rosiglitazone, pioglitazone pose similar CV risk in case-matched analysis - TheHeart.Org
Rosiglitazone, pioglitazone pose similar CV risk in case-matched analysisTheHeart.OrgAs recently covered by heartwire, the FDA put a "partial clinical hold" on enrollment into the TIDE trial while it considers the...
More Information »
Drug Safety Board's Advice Not Sought on FDA Avandia Deliberations - FDA news (subscription)
Drug Safety Board's Advice Not Sought on FDA Avandia DeliberationsFDA news (subscription)As the FDA continues its internal deliberations on whether to keep GlaxoSmithKline's (GSK) diabetes drug Avandia on the market,...
More Information »
Study Finds Avandia and Actos to Have Same Cardiovascular Risks - eMaxHealth
Study Finds Avandia and Actos to Have Same Cardiovascular RiskseMaxHealthAvandia has been recently reviewed for safety concerns by an FDA advisory panel. One study that was reviewed as part of the panel discussion was one...
More Information »
Diabetes Drug Avandia On Trial After Heart Attack Risk Allegations - Legal Info
Diabetes Drug Avandia On Trial After Heart Attack Risk AllegationsLegal InfoThe FDA has also said that GlaxoSmithKline failed to follow up on reported health problems and even patient deaths said to be caused by Avandia. ...
More Information »
Big Pharma Headed for More Deals, Less New Drug Applications - Seeking Alpha (blog)
Big Pharma Headed for More Deals, Less New Drug ApplicationsSeeking Alpha (blog)"Just recently, major reports have come out about biased, poor trials for Avandia and Avastin," Light said, who noted that orphan drugs...
More Information »
Advisory Committee Chair Calls for Tough Controls on Avandia - GoozNew (blog)
Advisory Committee Chair Calls for Tough Controls on AvandiaGoozNew (blog)Last month, the FDA's joint safety and metabolic drugs advisory committee meeting declared the diabetes drug Avandia (rosiglitazone) posed a...
More Information »
Whistleblower News Roundup 8.16.10 - Government Accountability Project (blog)
Whistleblower News Roundup 8.16.10Government Accountability Project (blog)The FDA's handling of the Avandia case (which greatly involves GAP client and noted whistleblower Dr. David Graham) highlights large systemic...
More Information »
Big Pharma: A "Market for Lemons" - Live in the Now
Live in the NowBig Pharma: A "Market for Lemons"Live in the Now... with clinical trial data in order to gain FDA approval of their diabetes drug, Avandia, knowing perfectly well that the drug carried significant...
More Information »
Is it safe to continue taking Avandia? - A Sweet Life (blog)
Is it safe to continue taking Avandia?A Sweet Life (blog)There is some evidence against use of Avandia and some evidence showing excellent safety, and the FDA panel did not recommend that the drug be withdrawn. ...
More Information »
An Interesting Year for FDA Watchers -- What Should They Do Next About ... - Medscape
An Interesting Year for FDA Watchers -- What Should They Do Next About ...MedscapeAvastin ® , a cancer drug, recently lost its indication for breast cancer, and rosiglitazone (Avandia ® ) was the subject of a very long and...
More Information »
Groundbreaking Web Technology Reveals Significant Patient Sentiment Change ... - PR Web (press release)
Groundbreaking Web Technology Reveals Significant Patient Sentiment Change ...PR Web (press release)... GSK, or the FDA. Wool.labs created a way to measure sentiment online, in order to provide a more in depth analysis of how...
More Information »
10 Years Later, Glaxo Still Haunted by Faked Studies of Paxil in Kids - BNET (blog)
10 Years Later, Glaxo Still Haunted by Faked Studies of Paxil in KidsBNET (blog)Ten years later, that lousy choice is still on GSK's agenda as the FDA decides whether its maneuvering on Avandia data is worthy of referral...
More Information »
Snacks Under 150 Calories - FitSugar.com (blog)
Snacks Under 150 CaloriesFitSugar.com (blog)Drug Safety Alert Rosiglitazone (Avandia) may significantly increase the risk for heart attack, indicates a review published in the Journal of the American ...and more »
More Information »
Vivus' Qnexa Panel Bodes Well for Arena's Obesity Drug - Seeking Alpha (blog)
Vivus' Qnexa Panel Bodes Well for Arena's Obesity DrugSeeking Alpha (blog)I think my views — I think it was both colored, maybe, by our experience with Avandia and the safety concerns that we should deal with them...
More Information »
Assault on Big Pharma Grows - 24/7 Wall St. (blog)
Assault on Big Pharma Grows24/7 Wall St. (blog)Many are also angry about the many blockbusters that fizzled such as Avandia and Avastin after companies were accused of hiding information about ...
More Information »
These Underdogs Are No Dogs - Motley Fool
These Underdogs Are No DogsMotley Fool... of GlaxoSmithKline's Avandia the day before it shot down Qnexa. It's expected that the FDA will give the word on both lorcaserin and Qnexa in October. ...
More Information »
Diabetes drugs Avandia, Actos both risky, according to health insurance ... - NewsOXY
Diabetes drugs Avandia, Actos both risky, according to health insurance ...NewsOXYAfter more reports of increased risk with the drug, an FDA advisory panel last month recommended even stronger warning labels. WellPoint Inc....
More Information »
|
|
| |